Klinische Studie

Krankheitsentität(en) Magen
StudientypInterventionsstudiePhase III
Wesentliche EinschlusskriterienHistologically and/or cytologically confirmed diagnosis of previously untreated, locally advanced unresectable or metastatic geastroesophageal adenocarcinoma Not HER 2 positiv Is not expected to require tumor resection during the treatment course
Wesentliche AusschlusskriterienHas Had previous therapy for locally advanced unresectable or metastatic gastric/GEJ/ esophageal adenovarcinoma. Has Haed major surgery within 28 days prior to first dose Has known CNS metastases
Statusrekrutierend
Ansprechpartner & KontaktUniversitätsklinikum RegensburgInnere Medizin IStudienzentrale0941 9447063studienzentrum.innere1(at)ukr.de